Legacy Capital Partners’s Abiomed Inc ABMD Stock Holding History

Legacy Capital Partners’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$864K	Sell	2,609 -600	-19%	-$185K	0.28%	75
2021 Q4	$1.15M	Buy	3,209 +30	+0.9%	+$10.1K	0.37%	70
2021 Q3	$1.03M	Sell	3,179 -100	-3%	-$33.9K	0.37%	69
2021 Q2	$1.02M	Sell	3,279 -1,011	-24%	-$310K	0.37%	72
2021 Q1	$1.37M	Sell	4,290 -1,271	-23%	-$407K	0.52%	57
2020 Q4	$1.8M	Buy	5,561 +1,765	+46%	+$488K	0.71%	48
2020 Q3	$1.05M	Buy	3,796 +750	+25%	+$216K	0.43%	62
2020 Q2	$736K	Buy	+3,046	New	+$612K	0.32%	70

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Legacy Capital Partners's ABMD Position: Q1 2022 in Review

Legacy Capital Partners reduced its Abiomed Inc (ABMD) stake by 19% in Q1 2022, selling an estimated $185K and leaving 2,609 shares worth $864K. The position accounts for 0.28% of the portfolio, ranked #75.

Legacy Capital Partners first reported a position in ABMD in Q2 2020 and has held it in 8 quarters since. The position peaked at $1.8M in Q4 2020. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

Legacy Capital Partners held 2,609 shares of Abiomed Inc worth $864K as of Q1 2022.
Legacy Capital Partners sold 600 Abiomed Inc shares in Q1 2022, an estimated $185K.
Abiomed Inc made up 0.28% of Legacy Capital Partners's portfolio in Q1 2022, its #75 holding.
Legacy Capital Partners first reported a position in Abiomed Inc in Q2 2020 and has held it in 8 quarters since.
Legacy Capital Partners's Abiomed Inc position peaked at $1.8M in Q4 2020.
500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on Legacy Capital Partners's 13F filing for Q1 2022, filed 11 Apr 2022.